Abstract
Cardiovascular effects of the tetracyclic antidepressant drug mianserin were examined in a prospective study including ten elderly depressed patients (age 60–77 years). During 1 week on placebo and 5 weeks on mianserin, 60 mg per day, orthostatic blood pressure testing, recording of standard electrocardiogram, 24-h electrocardiographic recording and systolic time intervals were carried out along with frequent monitoring of plasma levels of mianserin (13–57 μg/l) and the primary metabolite desmethylmianserin (7–27 μg/l). Mianserin caused a significant increase in orthostatic systolic blood pressure drop, and this correlated well with the plasma mianserin levels (r s=0.70). There were no significant changes in supine blood pressure or in orthostatic changes in heart rate. No cardiac conduction disturbances or arrhythmias were provoked, but mianserin caused changes in systolic time intervals indicating impairment of left ventricular contractility and performance. Like tricyclic antidepressants mianserin should thus be used with caution in patients with latent or overt cardiovascular disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Burckhardt D, Raeder E, Müller V, Imhof P, Neubauer H (1978) Cardiovascular effects of tricyclic and tetracyclic antidepressants. JAMA 239:213–216
Burgess CD, Montgomery S, Wadsworth J, Turner P (1979) Cardiovascular effects of amitriptyline, mianserin, zimelidine and nomifensine in depressed patients. Postgrad Med J 55:704–708
Fleisch JH (1981) Age-related decrease in beta-adrenoceptor activity of the cardiovascular system. TIPS 2:337–339
Fleischuss U, Sjöqvist F, Tuck D, Åsberg M (1970) Circulatory effects in man of nortriptyline, a tricyclic antidepressant drug. Pharmacol Clin 2:68–71
Ghose K, Coppen A, Turner P (1976) Autonomic actions and interactions of mianserin hydrochloride (Org BB 94) and amitriptyline in patients with depressive illness. Psychopharmacology 49:201–204
Giardina EV, Bigger JT, Glassman AH, Perel JM, Kantor SJ (1979) The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations. Circulation 60:1045–1049
Glassman AH, Bigger JT, Giardina EV, Kantor SJ, Perel JM, Davies M (1979) Clinical characteristics of imipramine-induced orthostatic hypotension. Lancet I:468–472
Gram LF (1983) Antidepressants: Receptors, pharmacokinetics and clinical effects. In: Burrows GD, Norman T and Davis B (eds) Drugs and psychiatry, vol I, Antidepressants. Elsevier/North-Holland (in press)
Gurney C, Roth M, Garside RF, Kerr TA, Schapira K (1972) Studies in the classification of affective disorder. The relationship between anxiety states and depressive illnesses. J Psychiatr 121:162–166
Hall H, Ögren SO (1981) Effects of antidepressant drugs on different receptors in the brain. Eur J Pharmacol 70:393–407
Hamilton M (1967) Development of a rating scale for primary depressive illness. J Soc Clin Psychol 6:278–296
Kopera H, Fluch N, Harpf H, Klein WW, Stulemeijer SM (1980) Cardiovascular effects of mianserin — a comparative study with amitriptyline and a placebo in healthy subjects. Int J Clin Pharmacol Ther Toxicol 18:104–109
Kragh-Sørensen P, Hansen CE, Baastrup PC, Hvidberg EF (1976) Self-inhibiting action of nortriptyline's antidepressive effect at high plasma levels: A randomized double-blind study controlled by plasma concentrations in patients with endogenous depression. Psychopharmacology 45:305–317
Lakatta EG (1980) Age-related alterations in the cardiovascular response to adrenergic mediated stress. Fed Proc 39:3173–3177
Montgomery S, McAuley, R, Montgomery DB (1978) Relationship between mianserin plasma levels and antidepressant effect in doubleblind trial comparing a single nighttime and divided daily dose regimens. Br J Clin Pharmacol 5:71S-76S
Nagy A, Treiber L (1973) Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thinlayer chromatograms. J Pharm Pharmacol 25:599–603
Nielsen JR, Johansen T, Arentoft A, Gram LF (1983) Effects of imipramine on the orthostatic changes in blood pressure, heart rate and plasma catecholamines. Clin Exp Pharmacol Physiol (in press)
Rowe JW, Troen BR (1980) Sympathetic nervous system and aging in man. Endocrine Reviews 1:167–179
Rudorfer MW, Young RC (1980) Desipramine: Cardiovascular effects and plasma levels. Am J Psychiatry 137:984–986
Taylor, JE, Braithwaite RA (1978) Cardiac effects of tricyclic antidepressant medication. Br Heart J 40:1005–1009
Thayssen P, Bjerre M, Kragh-Sørensen P, Møller M, Pedersen OL, Kristensen CB, Gram LF (1981) Cardiovascular effects of imipramine and nortriptyline in elderly patients. Psychopharmacology 74:360–364
Veith RC, Friedel RO, Bloom V, Bielski R (1980) Electrocardiogram changes and plasma desipramine levels during treatment of depression. Clin Pharmacol Ther 27:796–802
Videbæk J (1979) Isometric pressure indices. Thesis, Copenhagen
Vohra J, Burrows GD, Hunt D, Sloman G (1975) The effect of toxic and therapeutic doses of tricyclic antidepressant drug on intracardiac conduction. Eur J Cardiol 3:219–227
Weissler AM, Harris WS, Schoenfeld CD (1968) Systolic time intervals in heart failure in man. Circulation 37:149–159
Weissler, AM Harris WS, Schoenfeld CD (1969) Bedside technics for the evaluation of ventricular function in man. Am J Cardiol 23:577–583
Wester HA, Siegers CP (1980) Echocardiographic study in volunteers taking mianserin and amitriptyline. Curr Med Res Opin 6 suppl 7: 29–35
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Møller, M., Thayssen, P., Kragh-Sørensen, P. et al. Mianserin: Cardiovascular effects in elderly patients. Psychopharmacology 80, 174–177 (1983). https://doi.org/10.1007/BF00427964
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00427964